These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 36303197)

  • 1. Efficacy of platelet-rich plasma impregnation for unidirectional porous β-tricalcium phosphate in lateral lumbar interbody fusion: study protocol for a prospective controlled trial.
    Sato K; Funayama T; Noguchi H; Asada T; Kono M; Eto F; Shibao Y; Miura K; Kikuchi N; Yoshioka T; Takahashi H; Koda M; Yamazaki M
    Trials; 2022 Oct; 23(1):908. PubMed ID: 36303197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unidirectional porous β-tricalcium phosphate induces bony fusion in lateral lumbar interbody fusion.
    Kumagai H; Abe T; Koda M; Nagashima K; Miura K; Mataki K; Fujii K; Noguchi H; Funayama T; Yamazaki M
    J Clin Neurosci; 2019 Jan; 59():232-235. PubMed ID: 30244976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparing Bone Fusion Rates Between Novel Unidirectional Porous Tricalcium Beta-Phosphate and Autologous Bone in Lumbar Lateral Interbody Fusion: A Two-Year Radiographic Outcome Study.
    Kumagai H; Funayama T; Sato K; Noguchi H; Yoshioka T; Koda M; Yamazaki M
    Cureus; 2023 Sep; 15(9):e46240. PubMed ID: 37908955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet-rich plasma combined with hydroxyapatite for lumbar interbody fusion promoted bone formation and decreased an inflammatory pain neuropeptide in rats.
    Kamoda H; Yamashita M; Ishikawa T; Miyagi M; Arai G; Suzuki M; Eguchi Y; Orita S; Sakuma Y; Oikawa Y; Inoue G; Ozawa T; Toyone T; Wada Y; Takahashi K; Ohtori S
    Spine (Phila Pa 1976); 2012 Sep; 37(20):1727-33. PubMed ID: 22433505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved intervertebral bone union in ALIF rat model with porous hydroxyapatite/collagen combined with platelet-rich plasma.
    Matsubara T; Yamada K; Kanazawa T; Sato K; Yokosuka K; Shiba N
    Spine J; 2023 Feb; 23(2):325-335. PubMed ID: 36064089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the efficacy and safety of Escherichia coli-derived recombinant human bone morphogenetic protein-2 in transforaminal lumbar interbody fusion to treat degenerative spinal disease: a protocol of prospective, randomized controlled, assessor-blinded, open-label, multicenter trial.
    Choi JY; Park HJ; Park SM; Kang CN; Song KS
    J Orthop Surg Res; 2022 Aug; 17(1):397. PubMed ID: 36045371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet-rich plasma in mono-segmental posterior lumbar interbody fusion.
    Sys J; Weyler J; Van Der Zijden T; Parizel P; Michielsen J
    Eur Spine J; 2011 Oct; 20(10):1650-7. PubMed ID: 21744284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Use of artifiial bone in lateral interbody fusion of the lumbar spine: a prospective radiographic study].
    Hrabálek L; Čecháková E; Buřval S; Adamus M; Langová K; Vaverka M
    Acta Chir Orthop Traumatol Cech; 2014; 81(6):392-8. PubMed ID: 25651294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet-rich plasma enhances bone union in posterolateral lumbar fusion: A prospective randomized controlled trial.
    Kubota G; Kamoda H; Orita S; Yamauchi K; Sakuma Y; Oikawa Y; Inage K; Sainoh T; Sato J; Ito M; Yamashita M; Nakamura J; Suzuki T; Takahashi K; Ohtori S
    Spine J; 2019 Feb; 19(2):e34-e40. PubMed ID: 28735763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparing the early efficacies of autologous bone grafting and interbody fusion cages for treating degenerative lumbar instability in patients of different ages.
    Zhong HZ; Tian DS; Zhou Y; Jing JH; Qian J; Chen L; Zhu B
    Int Orthop; 2016 Jun; 40(6):1211-8. PubMed ID: 26830783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A unidirectional porous beta-tricalcium phosphate material (Affinos®) for reconstruction of bony defects after excision of fibular bone for spinal surgery graft.
    Noguchi H; Funayama T; Koda M; Iijima Y; Kumagai H; Ishikawa T; Aiba A; Abe T; Nagashima K; Miura K; Izawa S; Maki S; Furuya T; Yamazaki M
    J Clin Neurosci; 2019 Aug; 66():71-76. PubMed ID: 31174946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and radiographic outcomes of anterior lumbar interbody fusion using recombinant human bone morphogenetic protein-2.
    Burkus JK; Transfeldt EE; Kitchel SH; Watkins RG; Balderston RA
    Spine (Phila Pa 1976); 2002 Nov; 27(21):2396-408. PubMed ID: 12438990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anterior lumbar interbody fusion with carbon fiber cage loaded with bioceramics and platelet-rich plasma. An experimental study on pigs.
    Li H; Zou X; Xue Q; Egund N; Lind M; Bünger C
    Eur Spine J; 2004 Jul; 13(4):354-8. PubMed ID: 14730438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lumbar interbody fusion using the Brantigan I/F cage for posterior lumbar interbody fusion and the variable pedicle screw placement system: two-year results from a Food and Drug Administration investigational device exemption clinical trial.
    Brantigan JW; Steffee AD; Lewis ML; Quinn LM; Persenaire JM
    Spine (Phila Pa 1976); 2000 Jun; 25(11):1437-46. PubMed ID: 10828927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A protocol of a randomized controlled multicenter trial for surgical treatment of lumbar spondylolisthesis: the Lumbar Interbody Fusion Trial (LIFT).
    de Kunder SL; Rijkers K; van Kuijk SM; Evers SM; de Bie RA; van Santbrink H
    BMC Musculoskelet Disord; 2016 Oct; 17(1):417. PubMed ID: 27716168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Posterior lumbar interbody fusion using recombinant human bone morphogenetic protein type 2 with cylindrical interbody cages.
    Haid RW; Branch CL; Alexander JT; Burkus JK
    Spine J; 2004; 4(5):527-38; discussion 538-9. PubMed ID: 15363423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness and Feasibility of Injectable Escherichia coli-Derived Recombinant Human Bone Morphogenetic Protein-2 for Anterior Lumbar Interbody Fusion at the Lumbosacral Junction in Adult Spinal Deformity Surgery: A Clinical Pilot Study.
    Im SK; Lee JH; Lee KY; Yoo SJ
    Orthop Surg; 2022 Jul; 14(7):1350-1358. PubMed ID: 35633034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydroxyapatite/collagen composite graft for posterior lumbar interbody fusion: a comparison with local bone graft.
    Yoshii T; Hashimoto M; Egawa S; Hirai T; Inose H; Okawa A
    J Orthop Surg Res; 2021 Oct; 16(1):639. PubMed ID: 34689807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minimally invasive lateral interbody fusion for the treatment of rostral adjacent-segment lumbar degenerative stenosis without supplemental pedicle screw fixation.
    Wang MY; Vasudevan R; Mindea SA
    J Neurosurg Spine; 2014 Dec; 21(6):861-6. PubMed ID: 25303619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Preoperative Diagnosis on Clinical Outcomes of Oblique Lateral Interbody Fusion for Lumbar Degenerative Disease in a Single-institution Prospective Cohort.
    Chang SY; Nam Y; Lee J; Chang BS; Lee CK; Kim H
    Orthop Surg; 2019 Feb; 11(1):66-74. PubMed ID: 30767389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.